Zuraw B, Lumry WR, Johnston DT, Aygoren-Pursun E, et al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial. J Allergy Clin Immunol 2021;148:164-172.
PMID: 33098856